The effects of fenoterol inhalation after acid aspiration-induced lung injury

Anesthesia and Analgesia

Volumn 109, Issue 1, 2009, Pages 143-150

  Pawlik, Michael T ^a,c   Schubert, Thomas ^a   Hopf, Susanne ^a   Lubnow, Matthias ^a   Gruber, Michael ^a   Selig, Christoph ^b   Taeger, Kai ^a   Ittner, Karl P ^a  

^a University Hospital   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; HYDROCHLORIC ACID; INTERLEUKIN 6; PLACEBO; SEVOFLURANE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; ASPIRATION; BLOOD GAS ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENERAL ANESTHESIA; HISTOLOGY; INFLAMMATION; LIQUID CHROMATOGRAPHY; LUNG EDEMA; LUNG LAVAGE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; ANIMAL; ASPIRATION PNEUMONIA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; LUNG INJURY; MALE; METABOLISM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INHALATION; ANIMALS; FENOTEROL; HYDROCHLORIC ACID; LUNG INJURY; MALE; PNEUMONIA, ASPIRATION; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67650672132     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181a2a85d     Document Type: Article

References (31)

1. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993;78:56-62
2. Sakuma T, Hida M, Nambu Y, Osanai K, Toga H, Takahashi K, Ohya N, Inoue M, Watanabe Y. Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs. Jpn J Pharmacol 2001;85:161-6
3. Saldias FJ, Lecuona E, Comellas AP, Ridge KM, Sznajder JI. Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am J Respir Crit Care Med 1999;159:626-33
4. Dhingra VK, Uusaro A, Holmes CL, Walley KR. Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 2001;95:947-53
5. Sears MR, Lotvall J. Past, present and future-beta2-adrenoceptor agonists in asthma management. Respir Med 2005;99:152-70
6. Bloemen PG, van den Tweel MC, Henricks PA, Englels F, Kester MH, van de Loo PG, Blomjous FJ, Nijkamp FP. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am J Physiol 1997;272:L580-7
7. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173:281-7
8. Bernasconi M, Brandolese R, Poggi R, Manzin E, Rossi A. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med 1990;16:108-14
9. Pawlik MT, Schreyer AG, Ittner KP, Selig C, Gruber M, Feuer-bach S, Taeger K. Early treatment with pentoxifylline reduces lung injury induced by acid aspiration in rats. Chest 2005;127:613-21
10. Simons RK, Maier RV, Chi EY. Pulmonary effects of continuous endotoxin infusion in the rat. Circ Shock 1991;33:233-43
11. Palmieri TL, Enkhbaatar P, Bayliss R, Traber LD, Cox RA, Hawkins HK, Herndon DN, Greenhalgh DG, Traber DL. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med 2006;34:1719-24
12. Saldias FJ, Comellas A, Ridge KM, Lecuona E, Sznajder JI. Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia. J Appl Physiol 1999;87:30-5
13. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-83
14. Khimenko PL, Barnard JW, Moore TM, Wilson PS, Ballard ST, Taylor AE. Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol 1994;77:1116-21
15. Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995;99:461-6
16. van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994;62:2046-50
17. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32:1470-6
18. Ng A, Smith G. Gastroesophageal reflux and aspiration of gastric contents in anesthetic practice. Anesth Analg 2001;93:494-513
19. Berthiaume Y, Staub NC, Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987;79:335-43
20. Ishikawa T, Sekizawa SI, Sant'Ambrogio FB, Sant'Ambrogio G. Larynx vs. esophagus as reflexogenic sites for acid-induced bronchoconstriction in dogs. J Appl Physiol 1999;86:1226-30
21. Fine GF, Motoyama EK, Brandom BW, Fertal KM, Mutich R, Davis PJ. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium. Anesth Analg 2002;95:56-61, table of contents
22. Gattinoni L, Chiumello D, Russo R. Reduced tidal volumes and lung protective ventilatory strategies: where do we go from here? Curr Opin Crit Care 2002;8:45-50
23. Westervelt CL, Choe EU, Arya J, Lippton HL, Flint LM, Ferrara JJ. Effects of anti-inflammatory agents on hydrochloric acid-induced pulmonary injury. J Invest Surg 1996;9:283-91
24. Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury. Ann Surg 1990;212: 513-19, discussion 519-20
25. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523-35
26. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmo-nary expression of ICAM-1. Am J Pathol 1993;142:1739-49
27. Gu Y, Seidel A. Influence of salbutamol and isoproterenol on the production of TNF and reactive oxygen species by bovine alveolar macrophages and calcitriol differentiated HL-60 cells. Immunopharmacol Immunotoxicol 1996;18:115-28
28. Duggan M, McCaul CL, McNamara PJ, Englelberts D, Ackerley C, Kavanagh BP. Atelectasis causes vascular leak and lethal right ventricular failure in uninjured rat lungs. Am J Respir Crit Care Med 2003;167:1633-40
29. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Wa-tanabe S, Kobayashi J, Yamazaki F, Tanaka H, Inagaki N, Nagai H. Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 1997;54:144-52
30. Wu CC, Liao MH, Chen SJ, Chou TC, Chen A, Yen MH. Terbutaline prevents circulatory failure and mitigates mortality in rodents with endotoxemia. Shock 2000;14:60-7
31. Nader-Djalal N, Knight PR, Davidson BA, Johnson K. Hyperoxia exacerbates microvascular lung injury following acid aspiration. Chest 1997;112:1607-14